Paving the way to a bioresorbable technology: Development of the absorb BRS program (Q38995000)

8 September 2017

1 reference

title

Paving the way to a bioresorbable technology: Development of the absorb BRS program (English)

1 reference

8 September 2017

author name string

Laura E Leigh Perkins

1

1 reference

8 September 2017

Mary Beth Kossuth

2

1 reference

8 September 2017

Julia C Fox

3

1 reference

8 September 2017

Richard J Rapoza

4

1 reference

8 September 2017

publication date

1 November 2016

1 reference

Catheterization and Cardiovascular Interventions

8 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

volume

88

1 reference

8 September 2017

issue

S1

1 reference

8 September 2017

page(s)

1-9

1 reference

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months

8 September 2017

cites work

1 reference

Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.

21 January 2018

1 reference

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.

21 January 2018

1 reference

5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of p

21 January 2018

1 reference

Very late hazard with stenting versus balloon angioplasty for ST-elevation myocardial infarction: a 16-year single-center experience

21 January 2018

1 reference

Mechanisms of polymer degradation and erosion

21 January 2018

1 reference

Absorbable magnesium-based stent: physiological factors to consider for in vitro degradation assessments

21 January 2018

1 reference

Coronary stents: a materials perspective

21 January 2018

1 reference

Biodegradable Magnesium Alloys: A Review of Material Development and Applications

21 January 2018

1 reference

Magnesium in the murine artery: probing the products of corrosion

21 January 2018

1 reference

Current status of bioresorbable scaffolds in the treatment of coronary artery disease

21 January 2018

1 reference

Magnesium as a biodegradable and bioabsorbable material for medical implants

21 January 2018

1 reference

A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materials.

21 January 2018

1 reference

Short-term effects of biocorrodible iron stents in porcine coronary arteries

21 January 2018

1 reference

A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits

21 January 2018

1 reference

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

21 January 2018

1 reference

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

21 January 2018

1 reference

Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries

21 January 2018

1 reference

Drug eluting stents: are human and animal studies comparable?

21 January 2018

1 reference

Compensatory enlargement of human atherosclerotic coronary arteries

21 January 2018

1 reference

Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo

21 January 2018

1 reference

Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries

21 January 2018

1 reference

Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model

21 January 2018

1 reference

First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study

21 January 2018

1 reference

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

21 January 2018

1 reference

On the mechanisms of biocompatibility

21 January 2018

1 reference

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group

21 January 2018

1 reference

Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation

21 January 2018

1 reference

Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems

21 January 2018

1 reference

Bioresorption and Vessel Wall Integration of a Fully Bioresorbable Polymeric Everolimus-Eluting Scaffold: Optical Coherence Tomography, Intravascular Ultrasound, and Histological Study in a Porcine Model With 4-Year Follow-Up

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CCD.26811

1 reference

8 September 2017

1 reference